Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 4.98919329 |
2 | Golgi transport vesicle coating (GO:0048200) | 4.98919329 |
3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.91952045 |
4 | DNA deamination (GO:0045006) | 4.61712316 |
5 | protein maturation by protein folding (GO:0022417) | 4.61045036 |
6 | ATP synthesis coupled proton transport (GO:0015986) | 4.51648208 |
7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.51648208 |
8 | regulation of mitochondrial translation (GO:0070129) | 4.45903859 |
9 | cullin deneddylation (GO:0010388) | 4.18408275 |
10 | proteasome assembly (GO:0043248) | 4.18278221 |
11 | protein deneddylation (GO:0000338) | 4.10547107 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02450121 |
13 | negative regulation of cell killing (GO:0031342) | 4.02450121 |
14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.01496157 |
15 | oxidative phosphorylation (GO:0006119) | 3.94786422 |
16 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.93559919 |
17 | rhodopsin mediated signaling pathway (GO:0016056) | 3.90689520 |
18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88348057 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76885617 |
20 | respiratory electron transport chain (GO:0022904) | 3.76135647 |
21 | protein complex biogenesis (GO:0070271) | 3.71164738 |
22 | response to pheromone (GO:0019236) | 3.70784153 |
23 | electron transport chain (GO:0022900) | 3.69438218 |
24 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.65529638 |
25 | chaperone-mediated protein transport (GO:0072321) | 3.64289294 |
26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.62803227 |
27 | oxygen transport (GO:0015671) | 3.62180149 |
28 | * GDP-mannose metabolic process (GO:0019673) | 3.62052271 |
29 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.61349627 |
30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.57909012 |
31 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.57787962 |
32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.57594802 |
33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.55544126 |
34 | protein targeting to mitochondrion (GO:0006626) | 3.47927716 |
35 | establishment of protein localization to mitochondrion (GO:0072655) | 3.46370060 |
36 | formation of translation preinitiation complex (GO:0001731) | 3.44421689 |
37 | detection of bacterium (GO:0016045) | 3.43300364 |
38 | * GMP metabolic process (GO:0046037) | 3.41868267 |
39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41468469 |
40 | protein retention in ER lumen (GO:0006621) | 3.39473894 |
41 | regulation of oxidative phosphorylation (GO:0002082) | 3.36544480 |
42 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.32560539 |
43 | detection of other organism (GO:0098543) | 3.32103209 |
44 | signal peptide processing (GO:0006465) | 3.30411243 |
45 | peptidyl-histidine modification (GO:0018202) | 3.29762146 |
46 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.25358106 |
47 | NADH dehydrogenase complex assembly (GO:0010257) | 3.25358106 |
48 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.25358106 |
49 | ribonucleoprotein complex disassembly (GO:0032988) | 3.24347493 |
50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.20901688 |
51 | termination of RNA polymerase III transcription (GO:0006386) | 3.20901688 |
52 | protein localization to mitochondrion (GO:0070585) | 3.19953327 |
53 | gas transport (GO:0015669) | 3.19344806 |
54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.19082491 |
55 | negative regulation of ligase activity (GO:0051352) | 3.19082491 |
56 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.17275801 |
57 | neutrophil activation involved in immune response (GO:0002283) | 3.16243435 |
58 | inner mitochondrial membrane organization (GO:0007007) | 3.15923972 |
59 | * guanosine-containing compound biosynthetic process (GO:1901070) | 3.15460307 |
60 | retinal cone cell development (GO:0046549) | 3.14771472 |
61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.14073211 |
62 | regulation of defense response to virus by virus (GO:0050690) | 3.13663035 |
63 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.12798066 |
64 | iron-sulfur cluster assembly (GO:0016226) | 3.11201365 |
65 | metallo-sulfur cluster assembly (GO:0031163) | 3.11201365 |
66 | viral protein processing (GO:0019082) | 3.08640269 |
67 | ribosomal small subunit assembly (GO:0000028) | 3.07154702 |
68 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.05138404 |
69 | NIK/NF-kappaB signaling (GO:0038061) | 3.03785887 |
70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.03708912 |
71 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00266126 |
72 | modulation by symbiont of host defense response (GO:0052031) | 3.00266126 |
73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00266126 |
74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00266126 |
75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00266126 |
76 | modulation by symbiont of host immune response (GO:0052553) | 3.00266126 |
77 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.00134611 |
78 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.00134611 |
79 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.00134611 |
80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.00015902 |
81 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99848474 |
82 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.99572010 |
83 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.99572010 |
84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98813079 |
85 | regulation of cellular amine metabolic process (GO:0033238) | 2.97889231 |
86 | detection of light stimulus involved in visual perception (GO:0050908) | 2.97678382 |
87 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.97678382 |
88 | 7-methylguanosine mRNA capping (GO:0006370) | 2.96629774 |
89 | purine nucleobase biosynthetic process (GO:0009113) | 2.95446054 |
90 | GTP biosynthetic process (GO:0006183) | 2.94815431 |
91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.94465455 |
92 | respiratory chain complex IV assembly (GO:0008535) | 2.94111698 |
93 | de novo protein folding (GO:0006458) | 2.93139080 |
94 | modulation by virus of host process (GO:0019054) | 2.91082139 |
95 | synaptic vesicle exocytosis (GO:0016079) | 2.90665496 |
96 | translation (GO:0006412) | 2.90597001 |
97 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90397749 |
98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.89683819 |
99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.89683819 |
100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89012097 |
101 | leukocyte aggregation (GO:0070486) | 2.87888085 |
102 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.87615714 |
103 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86088482 |
104 | positive thymic T cell selection (GO:0045059) | 2.86020784 |
105 | amino acid salvage (GO:0043102) | 2.86016567 |
106 | L-methionine salvage (GO:0071267) | 2.86016567 |
107 | L-methionine biosynthetic process (GO:0071265) | 2.86016567 |
108 | 7-methylguanosine RNA capping (GO:0009452) | 2.85369678 |
109 | RNA capping (GO:0036260) | 2.85369678 |
110 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84226867 |
111 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84226867 |
112 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.84129592 |
113 | cytochrome complex assembly (GO:0017004) | 2.83229141 |
114 | CTP metabolic process (GO:0046036) | 2.82229587 |
115 | CTP biosynthetic process (GO:0006241) | 2.82229587 |
116 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.81719046 |
117 | de novo posttranslational protein folding (GO:0051084) | 2.77827605 |
118 | virion assembly (GO:0019068) | 2.77462200 |
119 | organelle disassembly (GO:1903008) | 2.76820640 |
120 | pseudouridine synthesis (GO:0001522) | 2.76726722 |
121 | barbed-end actin filament capping (GO:0051016) | 2.76682663 |
122 | UTP biosynthetic process (GO:0006228) | 2.75214597 |
123 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.74948255 |
124 | cotranslational protein targeting to membrane (GO:0006613) | 2.74176884 |
125 | regulation of necrotic cell death (GO:0010939) | 2.74172566 |
126 | positive regulation of ligase activity (GO:0051351) | 2.73806388 |
127 | modulation by symbiont of host cellular process (GO:0044068) | 2.72790774 |
128 | protein targeting to ER (GO:0045047) | 2.72633317 |
129 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.70988903 |
130 | photoreceptor cell development (GO:0042461) | 2.70713601 |
131 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.69895165 |
132 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.69856408 |
133 | protein localization to endosome (GO:0036010) | 2.69370372 |
134 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.69258173 |
135 | nucleobase biosynthetic process (GO:0046112) | 2.68880673 |
136 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.68694698 |
137 | macrophage activation involved in immune response (GO:0002281) | 2.67359059 |
138 | response to peptidoglycan (GO:0032494) | 2.63390260 |
139 | signal complex assembly (GO:0007172) | 2.58361850 |
140 | negative regulation of necroptotic process (GO:0060546) | 2.57917761 |
141 | detection of external biotic stimulus (GO:0098581) | 2.57655421 |
142 | respiratory burst (GO:0045730) | 2.56302454 |
143 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53956326 |
144 | type I interferon signaling pathway (GO:0060337) | 2.53481412 |
145 | cellular response to type I interferon (GO:0071357) | 2.53481412 |
146 | phagosome maturation (GO:0090382) | 2.51375845 |
147 | hemoglobin metabolic process (GO:0020027) | 2.50344653 |
148 | heme biosynthetic process (GO:0006783) | 2.50078190 |
149 | response to type I interferon (GO:0034340) | 2.50065230 |
150 | negative regulation of necrotic cell death (GO:0060547) | 2.49257645 |
151 | mannose metabolic process (GO:0006013) | 2.47070558 |
152 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.45064336 |
153 | thymic T cell selection (GO:0045061) | 2.41699318 |
154 | synaptic vesicle maturation (GO:0016188) | 2.41568710 |
155 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.41339569 |
156 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.40810426 |
157 | protein targeting to plasma membrane (GO:0072661) | 2.39074061 |
158 | regulation of mast cell degranulation (GO:0043304) | 2.38923198 |
159 | regulation of necroptotic process (GO:0060544) | 2.38877908 |
160 | amino sugar catabolic process (GO:0046348) | 2.38260170 |
161 | regulation of regulated secretory pathway (GO:1903305) | 2.37978667 |
162 | negative regulation of interleukin-12 production (GO:0032695) | 2.37786214 |
163 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37686159 |
164 | regulation of leukocyte degranulation (GO:0043300) | 2.35527047 |
165 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.32077355 |
166 | actin nucleation (GO:0045010) | 2.31941278 |
167 | immunoglobulin mediated immune response (GO:0016064) | 2.30868990 |
168 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.30338222 |
169 | granulocyte activation (GO:0036230) | 2.28437706 |
170 | actin filament polymerization (GO:0030041) | 2.27217404 |
171 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.26670989 |
172 | mature B cell differentiation involved in immune response (GO:0002313) | 2.26654897 |
173 | pyrimidine-containing compound salvage (GO:0008655) | 2.26541089 |
174 | pyrimidine nucleoside salvage (GO:0043097) | 2.26541089 |
175 | negative regulation of glial cell proliferation (GO:0060253) | 2.25800465 |
176 | positive regulation of receptor recycling (GO:0001921) | 2.25211696 |
177 | cellular response to virus (GO:0098586) | 2.25029554 |
178 | neutrophil activation (GO:0042119) | 2.24139672 |
179 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.22664884 |
180 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.21310968 |
181 | regulation of ARF protein signal transduction (GO:0032012) | 2.21246708 |
182 | heme metabolic process (GO:0042168) | 2.20247461 |
183 | glutamate secretion (GO:0014047) | 2.19791942 |
184 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.19390535 |
185 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.18313644 |
186 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.17192825 |
187 | response to host immune response (GO:0052572) | 2.17192825 |
188 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.17064394 |
189 | negative regulation of stress fiber assembly (GO:0051497) | 2.16456045 |
190 | positive T cell selection (GO:0043368) | 2.15805172 |
191 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.15145145 |
192 | negative regulation of innate immune response (GO:0045824) | 2.14706969 |
193 | positive regulation of protein dephosphorylation (GO:0035307) | 2.14573305 |
194 | detection of biotic stimulus (GO:0009595) | 2.14235433 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.47041952 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.17330368 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.13550328 |
4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.08700917 |
5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.01455811 |
6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.80331133 |
7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.77570697 |
8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.61197528 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.51720467 |
10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.22120137 |
11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.12104886 |
12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.09688267 |
13 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.99809888 |
14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.84887645 |
15 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.77099058 |
16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74096927 |
17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.69038405 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67052793 |
19 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.46299519 |
20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.44593548 |
21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.43506649 |
22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.37183686 |
23 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.36101432 |
24 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.36054617 |
25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.35996871 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34556512 |
27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.30861147 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27986673 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25027825 |
30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.24543628 |
31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.22924400 |
32 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19530082 |
33 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.19261646 |
34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.07240966 |
35 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 2.06464002 |
36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03087879 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00816344 |
38 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95586602 |
39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95431009 |
40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95212535 |
41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.94020551 |
42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92396512 |
43 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.91756485 |
44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.87532748 |
45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.87317095 |
46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85439873 |
47 | * DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.83517256 |
48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81429199 |
49 | P68_20966046_ChIP-Seq_HELA_Human | 1.78691478 |
50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.77986244 |
51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.70623323 |
52 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.70472515 |
53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.70335316 |
54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.70010098 |
55 | MYC_22102868_ChIP-Seq_BL_Human | 1.69296788 |
56 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.69010304 |
57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68948874 |
58 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.68918237 |
59 | MAF_26560356_Chip-Seq_TH1_Human | 1.68861555 |
60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68713726 |
61 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.68410682 |
62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67872625 |
63 | MAF_26560356_Chip-Seq_TH2_Human | 1.67838640 |
64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65643314 |
65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62833454 |
66 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61070359 |
67 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.60705569 |
68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.57487329 |
69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55720282 |
70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55201770 |
71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.53583186 |
72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.53258155 |
73 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52746521 |
74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52649703 |
75 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.52388146 |
76 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.52271878 |
77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51526582 |
78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50079399 |
79 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.49936620 |
80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48792606 |
81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47736513 |
82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46987504 |
83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.45637728 |
84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44885734 |
85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44111039 |
86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42685480 |
87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41592679 |
88 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39953074 |
89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39870290 |
90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39365241 |
91 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.38986174 |
92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.37798272 |
93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36571277 |
94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35899121 |
95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33230933 |
96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32618355 |
97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31886951 |
98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30881383 |
99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28946686 |
100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27953707 |
101 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.27796185 |
102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27061440 |
103 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.27036934 |
104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25690581 |
105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25480332 |
106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25357509 |
107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24712439 |
108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24583960 |
109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24250939 |
110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23668911 |
111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23492558 |
112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23295970 |
113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22246653 |
114 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21984787 |
115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20352279 |
116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19834581 |
117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19687394 |
118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19094173 |
119 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19077066 |
120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.18653331 |
121 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18301179 |
122 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18300530 |
123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18295358 |
124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17696505 |
125 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17183750 |
126 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17056646 |
127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16109214 |
128 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15225991 |
129 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14966691 |
130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14538807 |
131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14047186 |
132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13691497 |
133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13377559 |
134 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.13042638 |
135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12720603 |
136 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.12717234 |
137 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.12029023 |
138 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11238072 |
139 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10896932 |
140 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10643577 |
141 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10602185 |
142 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09692922 |
143 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09215268 |
144 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09150632 |
145 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08382896 |
146 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08190535 |
147 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07996315 |
148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07867666 |
149 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07227982 |
150 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07212510 |
151 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06467166 |
152 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05369678 |
153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04917421 |
154 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04600556 |
155 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04566407 |
156 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04454115 |
157 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04316973 |
158 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04253472 |
159 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02812511 |
160 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02354177 |
161 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02293842 |
162 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02054148 |
163 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96389529 |
164 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93373136 |
165 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93177779 |
166 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91780857 |
167 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90022206 |
168 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89755276 |
169 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89518837 |
170 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.89298370 |
171 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.88659432 |
172 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.87897630 |
173 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87183422 |
174 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85435623 |
175 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.83295872 |
176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.82891383 |
177 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82852908 |
178 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82775994 |
179 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82673955 |
180 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.82289825 |
181 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80527364 |
182 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80295921 |
183 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79937054 |
184 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.78948607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0006072_abnormal_retinal_apoptosis | 3.87470140 |
2 | MP0005551_abnormal_eye_electrophysiolog | 3.43515284 |
3 | MP0001986_abnormal_taste_sensitivity | 3.31753212 |
4 | MP0003436_decreased_susceptibility_to | 3.30628794 |
5 | MP0010386_abnormal_urinary_bladder | 3.10120281 |
6 | MP0004043_abnormal_pH_regulation | 3.02198307 |
7 | MP0003303_peritoneal_inflammation | 2.98106064 |
8 | MP0005451_abnormal_body_composition | 2.86993588 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.85050415 |
10 | MP0005058_abnormal_lysosome_morphology | 2.81834123 |
11 | MP0002909_abnormal_adrenal_gland | 2.78234181 |
12 | MP0005253_abnormal_eye_physiology | 2.75096572 |
13 | MP0003724_increased_susceptibility_to | 2.62998568 |
14 | MP0002638_abnormal_pupillary_reflex | 2.44159547 |
15 | MP0009840_abnormal_foam_cell | 2.34973810 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.33093222 |
17 | MP0006036_abnormal_mitochondrial_physio | 2.29989127 |
18 | MP0005025_abnormal_response_to | 2.28802869 |
19 | MP0004270_analgesia | 2.25562890 |
20 | MP0003693_abnormal_embryo_hatching | 2.19773938 |
21 | MP0002693_abnormal_pancreas_physiology | 2.19560103 |
22 | MP0003172_abnormal_lysosome_physiology | 2.19261048 |
23 | MP0000013_abnormal_adipose_tissue | 2.14084234 |
24 | MP0003329_amyloid_beta_deposits | 2.12582959 |
25 | MP0003011_delayed_dark_adaptation | 2.12234253 |
26 | MP0009785_altered_susceptibility_to | 2.09113532 |
27 | MP0005671_abnormal_response_to | 2.08003184 |
28 | MP0006082_CNS_inflammation | 2.07424087 |
29 | MP0003075_altered_response_to | 2.06636725 |
30 | MP0002419_abnormal_innate_immunity | 2.04736457 |
31 | MP0003806_abnormal_nucleotide_metabolis | 2.02621546 |
32 | MP0005000_abnormal_immune_tolerance | 2.02397675 |
33 | MP0003283_abnormal_digestive_organ | 1.97964101 |
34 | MP0001944_abnormal_pancreas_morphology | 1.96839443 |
35 | MP0001764_abnormal_homeostasis | 1.94382548 |
36 | MP0005220_abnormal_exocrine_pancreas | 1.91886521 |
37 | MP0004510_myositis | 1.91675598 |
38 | MP0000685_abnormal_immune_system | 1.89686028 |
39 | MP0001790_abnormal_immune_system | 1.89674277 |
40 | MP0005387_immune_system_phenotype | 1.89674277 |
41 | MP0002734_abnormal_mechanical_nocicepti | 1.86715652 |
42 | MP0005464_abnormal_platelet_physiology | 1.83550878 |
43 | MP0004947_skin_inflammation | 1.76392263 |
44 | MP0005083_abnormal_biliary_tract | 1.75996149 |
45 | MP0003183_abnormal_peptide_metabolism | 1.74969415 |
46 | MP0002735_abnormal_chemical_nociception | 1.74653497 |
47 | MP0001835_abnormal_antigen_presentation | 1.73014080 |
48 | MP0003705_abnormal_hypodermis_morpholog | 1.72066996 |
49 | MP0009333_abnormal_splenocyte_physiolog | 1.71346063 |
50 | MP0002148_abnormal_hypersensitivity_rea | 1.71201976 |
51 | MP0002420_abnormal_adaptive_immunity | 1.70289201 |
52 | MP0002723_abnormal_immune_serum | 1.68777557 |
53 | MP0001819_abnormal_immune_cell | 1.68403164 |
54 | MP0004858_abnormal_nervous_system | 1.68021109 |
55 | MP0004957_abnormal_blastocyst_morpholog | 1.66273808 |
56 | MP0003866_abnormal_defecation | 1.65739467 |
57 | MP0003763_abnormal_thymus_physiology | 1.65531171 |
58 | MP0001533_abnormal_skeleton_physiology | 1.64842597 |
59 | MP0000604_amyloidosis | 1.63686928 |
60 | MP0001529_abnormal_vocalization | 1.63520577 |
61 | MP0005084_abnormal_gallbladder_morpholo | 1.61792951 |
62 | MP0006276_abnormal_autonomic_nervous | 1.60104856 |
63 | MP0000858_altered_metastatic_potential | 1.58361189 |
64 | MP0006035_abnormal_mitochondrial_morpho | 1.57199354 |
65 | MP0001800_abnormal_humoral_immune | 1.55754190 |
66 | MP0004381_abnormal_hair_follicle | 1.54566802 |
67 | MP0002822_catalepsy | 1.54081912 |
68 | MP0002876_abnormal_thyroid_physiology | 1.53099493 |
69 | MP0010155_abnormal_intestine_physiology | 1.51717986 |
70 | MP0005379_endocrine/exocrine_gland_phen | 1.49288396 |
71 | MP0002452_abnormal_antigen_presenting | 1.47861645 |
72 | MP0003123_paternal_imprinting | 1.47448001 |
73 | MP0009278_abnormal_bone_marrow | 1.46836684 |
74 | MP0005423_abnormal_somatic_nervous | 1.46183994 |
75 | MP0002733_abnormal_thermal_nociception | 1.45996545 |
76 | MP0003646_muscle_fatigue | 1.44590900 |
77 | MP0001968_abnormal_touch/_nociception | 1.43968519 |
78 | MP0002877_abnormal_melanocyte_morpholog | 1.42995409 |
79 | MP0003300_gastrointestinal_ulcer | 1.42674160 |
80 | MP0005166_decreased_susceptibility_to | 1.41836321 |
81 | MP0000678_abnormal_parathyroid_gland | 1.41402600 |
82 | MP0005645_abnormal_hypothalamus_physiol | 1.40919257 |
83 | MP0001984_abnormal_olfaction | 1.40589172 |
84 | MP0002272_abnormal_nervous_system | 1.40551274 |
85 | MP0002229_neurodegeneration | 1.40299792 |
86 | MP0001970_abnormal_pain_threshold | 1.39563769 |
87 | MP0001905_abnormal_dopamine_level | 1.38777759 |
88 | MP0003879_abnormal_hair_cell | 1.38243872 |
89 | MP0000343_altered_response_to | 1.35803437 |
90 | MP0001845_abnormal_inflammatory_respons | 1.32487134 |
91 | MP0004215_abnormal_myocardial_fiber | 1.31827232 |
92 | MP0008874_decreased_physiological_sensi | 1.29386887 |
93 | MP0002736_abnormal_nociception_after | 1.29341259 |
94 | MP0003195_calcinosis | 1.29112799 |
95 | MP0001756_abnormal_urination | 1.26901530 |
96 | MP0003122_maternal_imprinting | 1.25172438 |
97 | MP0003880_abnormal_central_pattern | 1.24422932 |
98 | MP0000716_abnormal_immune_system | 1.23067561 |
99 | MP0004147_increased_porphyrin_level | 1.22849077 |
100 | MP0002132_abnormal_respiratory_system | 1.22767910 |
101 | MP0002078_abnormal_glucose_homeostasis | 1.22699529 |
102 | MP0008789_abnormal_olfactory_epithelium | 1.22003502 |
103 | MP0004859_abnormal_synaptic_plasticity | 1.21791616 |
104 | MP0001958_emphysema | 1.21652565 |
105 | MP0000749_muscle_degeneration | 1.21561060 |
106 | MP0008058_abnormal_DNA_repair | 1.21167630 |
107 | MP0002398_abnormal_bone_marrow | 1.19409866 |
108 | MP0003186_abnormal_redox_activity | 1.19332781 |
109 | MP0002405_respiratory_system_inflammati | 1.19286720 |
110 | MP0003635_abnormal_synaptic_transmissio | 1.17540541 |
111 | MP0004233_abnormal_muscle_weight | 1.17393930 |
112 | MP0003690_abnormal_glial_cell | 1.16736623 |
113 | MP0003656_abnormal_erythrocyte_physiolo | 1.16700544 |
114 | MP0003453_abnormal_keratinocyte_physiol | 1.14859656 |
115 | MP0002090_abnormal_vision | 1.14047956 |
116 | MP0000358_abnormal_cell_content/ | 1.13046485 |
117 | MP0008469_abnormal_protein_level | 1.12543951 |
118 | MP0005636_abnormal_mineral_homeostasis | 1.12385812 |
119 | MP0005646_abnormal_pituitary_gland | 1.08411990 |
120 | MP0005394_taste/olfaction_phenotype | 1.06218610 |
121 | MP0005499_abnormal_olfactory_system | 1.06218610 |
122 | MP0002429_abnormal_blood_cell | 1.04711166 |
123 | MP0002751_abnormal_autonomic_nervous | 1.04369775 |
124 | MP0001542_abnormal_bone_strength | 1.03625688 |
125 | MP0009764_decreased_sensitivity_to | 1.03567637 |
126 | MP0005195_abnormal_posterior_eye | 1.03492339 |
127 | MP0002653_abnormal_ependyma_morphology | 1.03197364 |
128 | MP0004036_abnormal_muscle_relaxation | 1.02953337 |
129 | MP0000920_abnormal_myelination | 1.02407576 |
130 | MP0006292_abnormal_olfactory_placode | 1.00863611 |
131 | MP0004084_abnormal_cardiac_muscle | 0.99977917 |
132 | MP0002933_joint_inflammation | 0.98963445 |
133 | MP0002163_abnormal_gland_morphology | 0.97661125 |
134 | MP0002722_abnormal_immune_system | 0.97558668 |
135 | MP0001849_ear_inflammation | 0.97288193 |
136 | MP0005535_abnormal_body_temperature | 0.97088174 |
137 | MP0004142_abnormal_muscle_tone | 0.97075198 |
138 | MP0003953_abnormal_hormone_level | 0.96045088 |
139 | MP0004133_heterotaxia | 0.94051531 |
140 | MP0003279_aneurysm | 0.93064978 |
141 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92889100 |
142 | MP0001873_stomach_inflammation | 0.92845361 |
143 | MP0000465_gastrointestinal_hemorrhage | 0.92023403 |
144 | MP0008438_abnormal_cutaneous_collagen | 0.91810116 |
145 | MP0000681_abnormal_thyroid_gland | 0.91072668 |
146 | MP0008260_abnormal_autophagy | 0.90555821 |
147 | MP0002184_abnormal_innervation | 0.90139879 |
148 | MP0000631_abnormal_neuroendocrine_gland | 0.89606462 |
149 | MP0000230_abnormal_systemic_arterial | 0.89215200 |
150 | MP0001545_abnormal_hematopoietic_system | 0.89020325 |
151 | MP0005397_hematopoietic_system_phenotyp | 0.89020325 |
152 | MP0003959_abnormal_lean_body | 0.88583731 |
153 | MP0002998_abnormal_bone_remodeling | 0.87944429 |
154 | MP0009780_abnormal_chondrocyte_physiolo | 0.87942905 |
155 | MP0009643_abnormal_urine_homeostasis | 0.87357108 |
156 | MP0001502_abnormal_circadian_rhythm | 0.87043941 |
157 | MP0004145_abnormal_muscle_electrophysio | 0.87004079 |
158 | MP0008932_abnormal_embryonic_tissue | 0.86900993 |
159 | MP0002269_muscular_atrophy | 0.86141018 |
160 | MP0008877_abnormal_DNA_methylation | 0.85787956 |
161 | MP0004811_abnormal_neuron_physiology | 0.85492318 |
162 | MP0002752_abnormal_somatic_nervous | 0.84947191 |
163 | MP0002332_abnormal_exercise_endurance | 0.84768929 |
164 | MP0002063_abnormal_learning/memory/cond | 0.84100807 |
165 | MP0002160_abnormal_reproductive_system | 0.83925792 |
166 | MP0005391_vision/eye_phenotype | 0.83613983 |
167 | MP0001851_eye_inflammation | 0.83491202 |
168 | MP0000689_abnormal_spleen_morphology | 0.83412761 |
169 | MP0005266_abnormal_metabolism | 0.82994670 |
170 | MP0005310_abnormal_salivary_gland | 0.82905747 |
171 | MP0001664_abnormal_digestion | 0.82190348 |
172 | MP0005165_increased_susceptibility_to | 0.79575690 |
173 | MP0005390_skeleton_phenotype | 0.79377674 |
174 | MP0003718_maternal_effect | 0.78850927 |
175 | MP0009745_abnormal_behavioral_response | 0.78746413 |
176 | MP0002882_abnormal_neuron_morphology | 0.78274148 |
177 | MP0005377_hearing/vestibular/ear_phenot | 0.78164705 |
178 | MP0003878_abnormal_ear_physiology | 0.78164705 |
179 | MP0002067_abnormal_sensory_capabilities | 0.78025410 |
180 | MP0000703_abnormal_thymus_morphology | 0.77978314 |
181 | MP0002796_impaired_skin_barrier | 0.75402700 |
182 | MP0003566_abnormal_cell_adhesion | 0.74622790 |
183 | MP0004185_abnormal_adipocyte_glucose | 0.74302824 |
184 | MP0001663_abnormal_digestive_system | 0.74026199 |
185 | MP0000015_abnormal_ear_pigmentation | 0.73856562 |
186 | MP0005075_abnormal_melanosome_morpholog | 0.73685623 |
187 | MP0005501_abnormal_skin_physiology | 0.72702830 |
188 | MP0008569_lethality_at_weaning | 0.72591124 |
189 | MP0003828_pulmonary_edema | 0.70808193 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Congenital stationary night blindness (HP:0007642) | 5.27971779 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 4.81121738 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.75092923 |
4 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.48283877 |
5 | Eczematoid dermatitis (HP:0000976) | 4.34752936 |
6 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.34436654 |
7 | Mitochondrial inheritance (HP:0001427) | 4.00343787 |
8 | Acute encephalopathy (HP:0006846) | 3.96929961 |
9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.80746597 |
10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.80746597 |
11 | Progressive macrocephaly (HP:0004481) | 3.79914002 |
12 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.72280597 |
13 | Abnormality of macrophages (HP:0004311) | 3.68039628 |
14 | Increased CSF lactate (HP:0002490) | 3.62843074 |
15 | Hepatic necrosis (HP:0002605) | 3.62826183 |
16 | Hypochromic microcytic anemia (HP:0004840) | 3.62584645 |
17 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.61460453 |
18 | Hepatocellular necrosis (HP:0001404) | 3.60362638 |
19 | Central scotoma (HP:0000603) | 3.51008106 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45249059 |
21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45249059 |
22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45249059 |
23 | Recurrent abscess formation (HP:0002722) | 3.27056524 |
24 | Recurrent bacterial skin infections (HP:0005406) | 3.24095924 |
25 | Abnormality of macular pigmentation (HP:0008002) | 3.18496718 |
26 | Dyschromatopsia (HP:0007641) | 3.18153226 |
27 | Severe visual impairment (HP:0001141) | 3.15108261 |
28 | Abnormal gallbladder physiology (HP:0012438) | 3.14483828 |
29 | Cholecystitis (HP:0001082) | 3.14483828 |
30 | Lactic acidosis (HP:0003128) | 3.09187676 |
31 | Obstructive lung disease (HP:0006536) | 3.05888544 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05888544 |
33 | Optic disc pallor (HP:0000543) | 3.02679611 |
34 | Progressive muscle weakness (HP:0003323) | 2.99500299 |
35 | Type I transferrin isoform profile (HP:0003642) | 2.97598315 |
36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.97558223 |
37 | Increased IgE level (HP:0003212) | 2.97440073 |
38 | Pheochromocytoma (HP:0002666) | 2.94874829 |
39 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.89320544 |
40 | Increased serum lactate (HP:0002151) | 2.88965131 |
41 | Neuroendocrine neoplasm (HP:0100634) | 2.85436541 |
42 | Hypoglycemic coma (HP:0001325) | 2.84331779 |
43 | Cerebral hypomyelination (HP:0006808) | 2.82811480 |
44 | Supranuclear gaze palsy (HP:0000605) | 2.82505719 |
45 | Myositis (HP:0100614) | 2.81507856 |
46 | Attenuation of retinal blood vessels (HP:0007843) | 2.81101579 |
47 | Exercise intolerance (HP:0003546) | 2.75798800 |
48 | Hypoglycemic seizures (HP:0002173) | 2.74200162 |
49 | Dysostosis multiplex (HP:0000943) | 2.74124090 |
50 | Vertebral compression fractures (HP:0002953) | 2.73358209 |
51 | Hypochromic anemia (HP:0001931) | 2.72930185 |
52 | Cellulitis (HP:0100658) | 2.70629598 |
53 | Gastrointestinal infarctions (HP:0005244) | 2.70346891 |
54 | Axonal loss (HP:0003447) | 2.67267054 |
55 | Interstitial pulmonary disease (HP:0006530) | 2.63618033 |
56 | Unsteady gait (HP:0002317) | 2.59605829 |
57 | Respiratory failure (HP:0002878) | 2.59422779 |
58 | Cerebral edema (HP:0002181) | 2.58423464 |
59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56366206 |
60 | Mediastinal lymphadenopathy (HP:0100721) | 2.56265918 |
61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.54377254 |
62 | Cholelithiasis (HP:0001081) | 2.52149520 |
63 | Petechiae (HP:0000967) | 2.50071662 |
64 | Decreased central vision (HP:0007663) | 2.49105057 |
65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.48925154 |
66 | Scotoma (HP:0000575) | 2.48732950 |
67 | Emotional lability (HP:0000712) | 2.47427188 |
68 | Slow saccadic eye movements (HP:0000514) | 2.46069477 |
69 | Hypertensive crisis (HP:0100735) | 2.45264189 |
70 | Ankle clonus (HP:0011448) | 2.45024242 |
71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.44881290 |
72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.44881290 |
73 | Abnormal protein glycosylation (HP:0012346) | 2.44881290 |
74 | Abnormal glycosylation (HP:0012345) | 2.44881290 |
75 | Microcytic anemia (HP:0001935) | 2.44709857 |
76 | Urticaria (HP:0001025) | 2.44402345 |
77 | Orchitis (HP:0100796) | 2.44271199 |
78 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.43276625 |
79 | Abnormality of alanine metabolism (HP:0010916) | 2.43276625 |
80 | Hyperalaninemia (HP:0003348) | 2.43276625 |
81 | Abnormal hemoglobin (HP:0011902) | 2.42451368 |
82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42138496 |
83 | Ketoacidosis (HP:0001993) | 2.40743214 |
84 | Increased muscle lipid content (HP:0009058) | 2.39619817 |
85 | Type II diabetes mellitus (HP:0005978) | 2.39016845 |
86 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.36777325 |
87 | Purpura (HP:0000979) | 2.31854100 |
88 | Myokymia (HP:0002411) | 2.31461532 |
89 | Cerebral inclusion bodies (HP:0100314) | 2.31381270 |
90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.31172997 |
91 | Amyloidosis (HP:0011034) | 2.30420951 |
92 | Polycythemia (HP:0001901) | 2.28447796 |
93 | Symptomatic seizures (HP:0011145) | 2.26873664 |
94 | Constricted visual fields (HP:0001133) | 2.26746261 |
95 | Palpitations (HP:0001962) | 2.25512921 |
96 | Delusions (HP:0000746) | 2.25306037 |
97 | Neurofibrillary tangles (HP:0002185) | 2.24875760 |
98 | Neuronal loss in central nervous system (HP:0002529) | 2.24303167 |
99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23994370 |
100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23889434 |
101 | Gingivitis (HP:0000230) | 2.23716487 |
102 | Meningitis (HP:0001287) | 2.22790964 |
103 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20350199 |
104 | Increased serum ferritin (HP:0003281) | 2.18857761 |
105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18586025 |
106 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18586025 |
107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18586025 |
108 | Abnormal number of erythroid precursors (HP:0012131) | 2.17787758 |
109 | Stomatitis (HP:0010280) | 2.16130391 |
110 | Distal lower limb muscle weakness (HP:0009053) | 2.16078025 |
111 | Pendular nystagmus (HP:0012043) | 2.14573492 |
112 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.14147317 |
113 | Generalized aminoaciduria (HP:0002909) | 2.14121386 |
114 | Abnormal gallbladder morphology (HP:0012437) | 2.12588152 |
115 | CNS demyelination (HP:0007305) | 2.11470255 |
116 | Increased serum pyruvate (HP:0003542) | 2.10851129 |
117 | Abnormality of glycolysis (HP:0004366) | 2.10851129 |
118 | Systemic lupus erythematosus (HP:0002725) | 2.10652878 |
119 | Abnormality of the nasal mucosa (HP:0000433) | 2.10284562 |
120 | Loss of speech (HP:0002371) | 2.10271988 |
121 | Growth hormone excess (HP:0000845) | 2.09574298 |
122 | Posterior subcapsular cataract (HP:0007787) | 2.09471409 |
123 | Recurrent fungal infections (HP:0002841) | 2.07541049 |
124 | Abnormality of the anterior horn cell (HP:0006802) | 2.06084774 |
125 | Degeneration of anterior horn cells (HP:0002398) | 2.06084774 |
126 | Aplastic anemia (HP:0001915) | 2.06063759 |
127 | Myoglobinuria (HP:0002913) | 2.05353474 |
128 | Episodic fever (HP:0001954) | 2.05264844 |
129 | Distal upper limb amyotrophy (HP:0007149) | 2.04694672 |
130 | Upper limb amyotrophy (HP:0009129) | 2.04694672 |
131 | Pigmentary retinal degeneration (HP:0001146) | 2.04588513 |
132 | Dysautonomia (HP:0002459) | 2.04271351 |
133 | Late onset (HP:0003584) | 2.03590835 |
134 | Recurrent skin infections (HP:0001581) | 2.02978719 |
135 | Hypertriglyceridemia (HP:0002155) | 2.02133001 |
136 | Visual hallucinations (HP:0002367) | 2.02065984 |
137 | J-shaped sella turcica (HP:0002680) | 2.01258565 |
138 | Hepatosplenomegaly (HP:0001433) | 1.99346906 |
139 | Increased cerebral lipofuscin (HP:0011813) | 1.97291918 |
140 | Gastrointestinal inflammation (HP:0004386) | 1.96622790 |
141 | Microretrognathia (HP:0000308) | 1.96157644 |
142 | Gait imbalance (HP:0002141) | 1.95978766 |
143 | Hypoplasia of the pons (HP:0012110) | 1.95609529 |
144 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95450633 |
145 | Mucopolysacchariduria (HP:0008155) | 1.95450633 |
146 | Hyperphosphaturia (HP:0003109) | 1.94705543 |
147 | Retinitis pigmentosa (HP:0000510) | 1.94188789 |
148 | Neoplasm of the adrenal gland (HP:0100631) | 1.93586500 |
149 | Hypergammaglobulinemia (HP:0010702) | 1.93113535 |
150 | Postnatal microcephaly (HP:0005484) | 1.93100696 |
151 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93012501 |
152 | Nasal polyposis (HP:0100582) | 1.92992884 |
153 | Congenital primary aphakia (HP:0007707) | 1.92981215 |
154 | Reticulocytosis (HP:0001923) | 1.92589965 |
155 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91992369 |
156 | Inflammation of the large intestine (HP:0002037) | 1.91866338 |
157 | Ventricular fibrillation (HP:0001663) | 1.91729683 |
158 | Leukodystrophy (HP:0002415) | 1.91452330 |
159 | Progressive neurologic deterioration (HP:0002344) | 1.90496949 |
160 | Hypothermia (HP:0002045) | 1.90148270 |
161 | Photophobia (HP:0000613) | 1.89876105 |
162 | Medial flaring of the eyebrow (HP:0010747) | 1.89509714 |
163 | Poor suck (HP:0002033) | 1.88450156 |
164 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88240381 |
165 | Gout (HP:0001997) | 1.87610324 |
166 | Achilles tendon contracture (HP:0001771) | 1.85560484 |
167 | Muscular hypotonia of the trunk (HP:0008936) | 1.83012826 |
168 | Lethargy (HP:0001254) | 1.82985431 |
169 | Ragged-red muscle fibers (HP:0003200) | 1.82393099 |
170 | Gastrointestinal dysmotility (HP:0002579) | 1.81999215 |
171 | Obstructive sleep apnea (HP:0002870) | 1.81157446 |
172 | Abnormality of iron homeostasis (HP:0011031) | 1.79835393 |
173 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.79206517 |
174 | Glycosuria (HP:0003076) | 1.78745562 |
175 | Abnormality of urine glucose concentration (HP:0011016) | 1.78745562 |
176 | Retrobulbar optic neuritis (HP:0100654) | 1.78413379 |
177 | Optic neuritis (HP:0100653) | 1.78413379 |
178 | EEG with generalized epileptiform discharges (HP:0011198) | 1.78406645 |
179 | Stridor (HP:0010307) | 1.78329622 |
180 | Colitis (HP:0002583) | 1.78211324 |
181 | Pustule (HP:0200039) | 1.78167195 |
182 | Abnormal pancreas size (HP:0012094) | 1.77830016 |
183 | Myopathic facies (HP:0002058) | 1.76319241 |
184 | Epistaxis (HP:0000421) | 1.74999503 |
185 | Spontaneous hematomas (HP:0007420) | 1.74465167 |
186 | Peripheral hypomyelination (HP:0007182) | 1.72780304 |
187 | Distal lower limb amyotrophy (HP:0008944) | 1.72036335 |
188 | Increased IgM level (HP:0003496) | 1.71929788 |
189 | Abnormality of the gallbladder (HP:0005264) | 1.71721856 |
190 | Agammaglobulinemia (HP:0004432) | 1.71332061 |
191 | Vasculitis (HP:0002633) | 1.70941479 |
192 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.70427719 |
193 | Rapidly progressive (HP:0003678) | 1.69519614 |
194 | Hand muscle atrophy (HP:0009130) | 1.69195695 |
195 | Prolonged bleeding time (HP:0003010) | 1.68556945 |
196 | Abnormality of binocular vision (HP:0011514) | 1.68226215 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME1 | 3.31517521 |
2 | ERN1 | 3.12185183 |
3 | NME2 | 2.97213961 |
4 | ARAF | 2.94742623 |
5 | NEK1 | 2.93548015 |
6 | BUB1 | 2.93541511 |
7 | TRIB3 | 2.89968241 |
8 | STK16 | 2.77388737 |
9 | BCKDK | 2.72645046 |
10 | SCYL2 | 2.70513231 |
11 | PRPF4B | 2.61125811 |
12 | RIPK4 | 2.53806114 |
13 | EIF2AK1 | 2.49943150 |
14 | MAP3K12 | 2.35591781 |
15 | PRKD3 | 2.32517177 |
16 | PASK | 2.29860649 |
17 | BRAF | 2.19528579 |
18 | PINK1 | 2.15411843 |
19 | MAP4K1 | 2.06416565 |
20 | GRK6 | 2.05817156 |
21 | MAP2K3 | 2.01769114 |
22 | TAOK2 | 2.01024077 |
23 | EIF2AK3 | 1.95792798 |
24 | MAPK15 | 1.91250560 |
25 | TESK1 | 1.91022947 |
26 | INSRR | 1.76405589 |
27 | MINK1 | 1.65014279 |
28 | TNK2 | 1.63488236 |
29 | TAOK1 | 1.62290513 |
30 | VRK1 | 1.57627895 |
31 | WNK3 | 1.55995898 |
32 | MARK1 | 1.55163237 |
33 | TESK2 | 1.55063227 |
34 | IRAK4 | 1.54900092 |
35 | TBK1 | 1.52118621 |
36 | CAMKK2 | 1.48231155 |
37 | ZAP70 | 1.48207290 |
38 | PIM2 | 1.46924411 |
39 | MAP3K11 | 1.45341136 |
40 | FES | 1.45245977 |
41 | SIK1 | 1.42794916 |
42 | TYK2 | 1.38375808 |
43 | PAK6 | 1.34172924 |
44 | EPHB1 | 1.33471562 |
45 | BLK | 1.31479113 |
46 | LIMK1 | 1.30404892 |
47 | MAP3K2 | 1.28291165 |
48 | MYLK | 1.26924557 |
49 | TSSK6 | 1.26587632 |
50 | WEE1 | 1.22759306 |
51 | SIK2 | 1.20563745 |
52 | PBK | 1.18948198 |
53 | FLT3 | 1.17064275 |
54 | SMG1 | 1.13990435 |
55 | EPHA2 | 1.12253437 |
56 | MARK2 | 1.11731293 |
57 | BRSK1 | 1.10958880 |
58 | NTRK3 | 1.10155984 |
59 | DAPK1 | 1.09989650 |
60 | STK38L | 1.09287429 |
61 | PRKD2 | 1.08398173 |
62 | PKN2 | 1.08339102 |
63 | MAPKAPK3 | 1.07151388 |
64 | CSK | 1.05146817 |
65 | PRKCI | 0.99256354 |
66 | AURKA | 0.99112379 |
67 | BRSK2 | 0.98617984 |
68 | DAPK2 | 0.97328550 |
69 | GRK5 | 0.96651553 |
70 | CCNB1 | 0.95945719 |
71 | GRK1 | 0.95765601 |
72 | LRRK2 | 0.94051287 |
73 | AKT3 | 0.93678456 |
74 | PDPK1 | 0.91424157 |
75 | MAP2K2 | 0.91192518 |
76 | SRPK1 | 0.90892264 |
77 | WNK4 | 0.90534008 |
78 | DYRK3 | 0.89704439 |
79 | MAPK12 | 0.87084949 |
80 | NTRK1 | 0.86850848 |
81 | ACVR1B | 0.86281542 |
82 | ZAK | 0.84854157 |
83 | DYRK2 | 0.84559477 |
84 | MAP2K7 | 0.83969217 |
85 | IRAK3 | 0.82855410 |
86 | RIPK1 | 0.81991200 |
87 | IKBKE | 0.81788537 |
88 | HCK | 0.81431064 |
89 | KSR2 | 0.81255464 |
90 | BCR | 0.80873922 |
91 | MAP3K9 | 0.80212918 |
92 | PDK1 | 0.78209229 |
93 | PTK6 | 0.77566490 |
94 | ICK | 0.76828099 |
95 | BMX | 0.75799432 |
96 | SYK | 0.75697812 |
97 | MAP3K13 | 0.75457219 |
98 | PAK4 | 0.74372844 |
99 | STK38 | 0.73783167 |
100 | PLK3 | 0.72436951 |
101 | BTK | 0.72001376 |
102 | LMTK2 | 0.70994289 |
103 | JAK3 | 0.70333388 |
104 | UHMK1 | 0.68162939 |
105 | IRAK2 | 0.68056797 |
106 | KDR | 0.67388537 |
107 | PLK4 | 0.66404715 |
108 | CAMK2D | 0.65503833 |
109 | MAP3K6 | 0.65072512 |
110 | CAMKK1 | 0.62456522 |
111 | CDK19 | 0.61676081 |
112 | MAP3K1 | 0.61347234 |
113 | RAF1 | 0.59058382 |
114 | MAP2K6 | 0.59000018 |
115 | JAK2 | 0.58204220 |
116 | FGR | 0.58100329 |
117 | BMPR1B | 0.56565384 |
118 | PHKG1 | 0.55059891 |
119 | PHKG2 | 0.55059891 |
120 | EPHA4 | 0.54896785 |
121 | RPS6KA2 | 0.54713779 |
122 | DAPK3 | 0.53719536 |
123 | CDK14 | 0.52888097 |
124 | DYRK1B | 0.52602106 |
125 | CDC42BPA | 0.52485616 |
126 | RPS6KA4 | 0.50554570 |
127 | PLK1 | 0.50411389 |
128 | MAPK13 | 0.50231995 |
129 | FYN | 0.50084916 |
130 | PRKG2 | 0.49672855 |
131 | MOS | 0.49353070 |
132 | PDK3 | 0.49045916 |
133 | PDK4 | 0.49045916 |
134 | FGFR4 | 0.48564652 |
135 | MAP3K4 | 0.48493307 |
136 | SIK3 | 0.48361328 |
137 | LCK | 0.47392282 |
138 | PRKCG | 0.46214441 |
139 | LYN | 0.45931444 |
140 | CAMK2G | 0.45445245 |
141 | IKBKB | 0.45431702 |
142 | ERBB3 | 0.45122693 |
143 | MAPK11 | 0.45108741 |
144 | PRKD1 | 0.43233578 |
145 | CSNK2A2 | 0.42684123 |
146 | ABL2 | 0.42633142 |
147 | PTK2B | 0.42234711 |
148 | MAP3K5 | 0.42183469 |
149 | HIPK2 | 0.41740099 |
150 | TXK | 0.41629437 |
151 | MAP2K1 | 0.40915094 |
152 | RET | 0.40730654 |
153 | IRAK1 | 0.40528620 |
154 | CSNK2A1 | 0.40389816 |
155 | TGFBR2 | 0.39817170 |
156 | FRK | 0.39386457 |
157 | RPS6KC1 | 0.39292546 |
158 | RPS6KL1 | 0.39292546 |
159 | PAK1 | 0.39144847 |
160 | CDK5 | 0.38184979 |
161 | MAP2K4 | 0.37834747 |
162 | ILK | 0.36340973 |
163 | DYRK1A | 0.35591200 |
164 | BMPR2 | 0.35331478 |
165 | RPS6KB2 | 0.33707267 |
166 | RPS6KA5 | 0.33666742 |
167 | MAP3K3 | 0.33219367 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 4.11154222 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.06174566 |
3 | Phototransduction_Homo sapiens_hsa04744 | 3.99147077 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.58912321 |
5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.42261614 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.29335150 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.80079372 |
8 | Ribosome_Homo sapiens_hsa03010 | 2.57580320 |
9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.52715904 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.37304814 |
11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.30299105 |
12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.18285815 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00543312 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.97519080 |
15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.94981209 |
16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.89974186 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82686013 |
18 | DNA replication_Homo sapiens_hsa03030 | 1.80272572 |
19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72018905 |
20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.67616804 |
21 | Malaria_Homo sapiens_hsa05144 | 1.67505501 |
22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65096076 |
23 | Mismatch repair_Homo sapiens_hsa03430 | 1.64034782 |
24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62449689 |
25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59526226 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.59223463 |
27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58719352 |
28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58016803 |
29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57740652 |
30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.54878004 |
31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54642800 |
32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53931815 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.52417614 |
34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.52414617 |
35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51155484 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.50576249 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.46503557 |
38 | * Purine metabolism_Homo sapiens_hsa00230 | 1.45845212 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44818399 |
40 | Endocytosis_Homo sapiens_hsa04144 | 1.41736655 |
41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39459369 |
42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39392342 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37489749 |
44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37092505 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29659663 |
46 | RNA transport_Homo sapiens_hsa03013 | 1.28462426 |
47 | Phagosome_Homo sapiens_hsa04145 | 1.28425226 |
48 | Spliceosome_Homo sapiens_hsa03040 | 1.25852969 |
49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25800958 |
50 | Prion diseases_Homo sapiens_hsa05020 | 1.25293887 |
51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23143466 |
52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22292372 |
53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19667041 |
54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19239153 |
55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17947932 |
56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16772971 |
57 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13032943 |
58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12584094 |
59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10594465 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10558804 |
61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09626917 |
62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09432844 |
63 | Allograft rejection_Homo sapiens_hsa05330 | 1.09015757 |
64 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08755779 |
65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08310513 |
66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07507092 |
67 | Base excision repair_Homo sapiens_hsa03410 | 1.06266303 |
68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02774918 |
69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00652874 |
70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99753696 |
71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97845261 |
72 | Pertussis_Homo sapiens_hsa05133 | 0.94084275 |
73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93456136 |
74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92848800 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91432359 |
76 | Hepatitis C_Homo sapiens_hsa05160 | 0.91079953 |
77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90124651 |
78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89742107 |
79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89087578 |
80 | Apoptosis_Homo sapiens_hsa04210 | 0.87738589 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86666719 |
82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86216899 |
83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85235328 |
84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85131892 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84931676 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84440779 |
87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83290140 |
88 | Homologous recombination_Homo sapiens_hsa03440 | 0.81376018 |
89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81293953 |
90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80699427 |
91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80235707 |
92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79829933 |
93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79796145 |
94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79645531 |
95 | Measles_Homo sapiens_hsa05162 | 0.79277665 |
96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77186388 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76196174 |
98 | RNA degradation_Homo sapiens_hsa03018 | 0.75751616 |
99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75545534 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74688997 |
101 | Influenza A_Homo sapiens_hsa05164 | 0.74288602 |
102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71688039 |
103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70231896 |
104 | Legionellosis_Homo sapiens_hsa05134 | 0.69257849 |
105 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.68953094 |
106 | Glioma_Homo sapiens_hsa05214 | 0.68143436 |
107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66804712 |
108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66436184 |
109 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65811216 |
110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65486770 |
111 | Bladder cancer_Homo sapiens_hsa05219 | 0.65318289 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65188108 |
113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63623686 |
114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61795422 |
115 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61495185 |
116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60314578 |
117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59208954 |
118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58630920 |
119 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58432692 |
120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57473510 |
121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57386553 |
122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56082571 |
123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55742816 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55111074 |
125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54370954 |
126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54183252 |
127 | Taste transduction_Homo sapiens_hsa04742 | 0.54073557 |
128 | Hepatitis B_Homo sapiens_hsa05161 | 0.52468834 |
129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51998407 |
130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50512844 |
131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49097224 |
132 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48838474 |
133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48430674 |
134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48241456 |
135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47776805 |
136 | Morphine addiction_Homo sapiens_hsa05032 | 0.47356884 |
137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47170283 |
138 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47103220 |
139 | Alcoholism_Homo sapiens_hsa05034 | 0.46801662 |
140 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45234090 |
141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44968250 |
142 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44553981 |
143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43234354 |
144 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42895619 |
145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42422593 |
146 | Nicotine addiction_Homo sapiens_hsa05033 | 0.41425832 |
147 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39971793 |
148 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39529325 |
149 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39178152 |
150 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38484321 |
151 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38025939 |
152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37792648 |
153 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37413345 |
154 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35893990 |
155 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35158871 |
156 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35043085 |
157 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34260958 |
158 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33569939 |
159 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33337552 |
160 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31772970 |
161 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31378377 |
162 | Lysosome_Homo sapiens_hsa04142 | 0.29426271 |
163 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28894929 |
164 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26893072 |
165 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25990612 |
166 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.25213513 |
167 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25050027 |
168 | Cell cycle_Homo sapiens_hsa04110 | 0.22786659 |
169 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21057613 |
170 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20429709 |
171 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19807484 |
172 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18772128 |
173 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17920829 |